Research suggests one shot may change cholesterol care

Researchers have developed a single gene injection that could revolutionize the treatment of harmful cholesterol. The technique employed gene editing to target the PCSK9 gene, which is responsible for regulating blood cholesterol levels. A trial involving 35 adults with genetically high cholesterol showed that permanent modification of the gene significantly reduced LDL (bad) cholesterol levels. The long-term follow-up continues for up to 15 years. This experimental treatment is considered an important step toward reducing reliance on daily medications and achieving permanent stability in cholesterol levels.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل